
Gene Synthesis Market Report and Forecast 2025-2034
Description
The global gene synthesis market size was valued at USD 2.42 Billion in 2024, driven by the increasing prevalence of genetic disorders across the globe. The market is anticipated to grow at a CAGR of 21.20% during the forecast period of 2025-2034 to achieve a value of USD 16.55 Billion by 2034.
Gene Synthesis: Introduction
Gene synthesis is a method which is used to generate or produce artificial genes in the laboratory. It enables the scientists to design and build custom DNA sequences that can later be used to manipulate the behaviours and characteristics of organisms or humans. Scientists insert these altered DNA into the body of the target and then observe the outcomes of the underlying experiments or trials. The complete process of gene synthesis consists of five steps including design, synthesis, assembly, verification, and expression. At first, the designing of sequence is being done by keeping the expected functionality of the living cell in mind. Then the gene synthesis takes place which is processed chemically. The basic building blocks of DNA (adenine, thymine, guanine, and cytosine) are linked together in the order specified by the design. The small, synthesized fragments are then assembled into full-length genes. This can be done with the use of a variety of methods such as polymerase chain reaction (PCR). Then happens the verification.
It is basically matching the intended design with the outcome of assembled gene. The synthesized gene at this stage is ready to be inserted into a living cell (like a bacteria or yeast cell) to "express" the gene, which means that the cell will read the DNA sequence and produce the protein that the gene has been coded for.
Global Gene Synthesis Market Analysis
Gene synthesis can be used in various fields including vaccine development, drug discovery, agricultural biotechnology, and many other areas of biotechnology and life sciences. The increasing demand of gene synthesis in the fields such as pharmaceuticals and biotechnology industries has been driving the global gene synthesis market growth. The gene synthesis is widely applicable in the development of drugs. Pharmaceutical companies along with biotech companies are suing gene synthesis to develop new therapies such as personalized medicines and vaccines.
Additionally, the increasing technological advancements in the field of synthetic biology are making gene synthesis to be more efficient and cost-effective. This includes updating gene design software, DNA synthesis and assembly technologies, and techniques for integrating synthetic genes into host organisms. The market is witnessing increased funding and investment from both public and private sources. This is leading to increased rate of research and development activities and more innovation. The global gene synthesis market development is driven by the increased focus on using gene synthesis for agricultural applications, such as the development of genetically modified crops with improved traits.
Global Gene Synthesis Market Segmentation
The EMR’s report titled “Gene Synthesis Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Components
The increasing research and development in the fields of synthetic biology and genomics is driving demand for gene synthesis services. This is especially prevalent in sectors pharmaceuticals sector along with biotechnology, and academia. The increasing technological advancements in the field have made gene synthesis more efficient, accurate, and affordable which is helping in the market growth. Developments in next-generation sequencing, bioinformatics, and gene editing technologies (like CRISPR) are also directly contributing to market growth. The gene synthesis has been increasingly used in the discovery and development of novel drugs and therapeutics, including personalized medicines and vaccines.
Additionally, the increasing prevalence of genetic disorders worldwide is also driving the demand for effective genetic therapies boosting the market. There has been a rise in funding and investments from government and private sectors for research activities that are fuelling the global gene synthesis market expansion.
Global Gene Synthesis Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Gene Synthesis: Introduction
Gene synthesis is a method which is used to generate or produce artificial genes in the laboratory. It enables the scientists to design and build custom DNA sequences that can later be used to manipulate the behaviours and characteristics of organisms or humans. Scientists insert these altered DNA into the body of the target and then observe the outcomes of the underlying experiments or trials. The complete process of gene synthesis consists of five steps including design, synthesis, assembly, verification, and expression. At first, the designing of sequence is being done by keeping the expected functionality of the living cell in mind. Then the gene synthesis takes place which is processed chemically. The basic building blocks of DNA (adenine, thymine, guanine, and cytosine) are linked together in the order specified by the design. The small, synthesized fragments are then assembled into full-length genes. This can be done with the use of a variety of methods such as polymerase chain reaction (PCR). Then happens the verification.
It is basically matching the intended design with the outcome of assembled gene. The synthesized gene at this stage is ready to be inserted into a living cell (like a bacteria or yeast cell) to "express" the gene, which means that the cell will read the DNA sequence and produce the protein that the gene has been coded for.
Global Gene Synthesis Market Analysis
Gene synthesis can be used in various fields including vaccine development, drug discovery, agricultural biotechnology, and many other areas of biotechnology and life sciences. The increasing demand of gene synthesis in the fields such as pharmaceuticals and biotechnology industries has been driving the global gene synthesis market growth. The gene synthesis is widely applicable in the development of drugs. Pharmaceutical companies along with biotech companies are suing gene synthesis to develop new therapies such as personalized medicines and vaccines.
Additionally, the increasing technological advancements in the field of synthetic biology are making gene synthesis to be more efficient and cost-effective. This includes updating gene design software, DNA synthesis and assembly technologies, and techniques for integrating synthetic genes into host organisms. The market is witnessing increased funding and investment from both public and private sources. This is leading to increased rate of research and development activities and more innovation. The global gene synthesis market development is driven by the increased focus on using gene synthesis for agricultural applications, such as the development of genetically modified crops with improved traits.
Global Gene Synthesis Market Segmentation
The EMR’s report titled “Gene Synthesis Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Components
- Synthesizer
- Consumables
- Software and Services
- Standard Gene
- Express Gene
- Complex Gene
- Others
- Synthetic Biology
- Genetic Engineering
- Vaccine Design
- Therapeutics Antibodies
- Others
- Gene Library Synthesis
- Solid Phase Synthesis
- Chip-Based DNA Synthesis
- PCR-Based Enzyme Synthesis
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The increasing research and development in the fields of synthetic biology and genomics is driving demand for gene synthesis services. This is especially prevalent in sectors pharmaceuticals sector along with biotechnology, and academia. The increasing technological advancements in the field have made gene synthesis more efficient, accurate, and affordable which is helping in the market growth. Developments in next-generation sequencing, bioinformatics, and gene editing technologies (like CRISPR) are also directly contributing to market growth. The gene synthesis has been increasingly used in the discovery and development of novel drugs and therapeutics, including personalized medicines and vaccines.
Additionally, the increasing prevalence of genetic disorders worldwide is also driving the demand for effective genetic therapies boosting the market. There has been a rise in funding and investments from government and private sectors for research activities that are fuelling the global gene synthesis market expansion.
Global Gene Synthesis Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- ATDBio Ltd
- General Biosystems
- Macrogen CO.
- Boster Biological Technology
- Creative Biogene
- Bioneer Pacific,
- Exonbio
- trenzyme GmbH
- Twist Bioscience
- BioCat GmbH
- OriGene Technologies, Inc.
- Integrated DNA Technologies
- Eurofins Scientific
- NZYTech
- Genes and Enzymes
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Gene Synthesis Market Overview
- 3.1 Global Gene Synthesis Market Historical Value (2018-2024)
- 3.2 Global Gene Synthesis Market Forecast Value (2025-2034)
- 4 Global Gene Synthesis Market Landscape
- 4.1 Gene Synthesis: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Gene Synthesis: Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Applications
- 5 Global Gene Synthesis Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Gene Synthesis Market Segmentation
- 6.1 Global Gene Synthesis Market by Components
- 6.1.1 Market Overview
- 6.1.2 Synthesizer
- 6.1.3 Consumables
- 6.1.4 Software and Services
- 6.2 Global Gene Synthesis Market by Gene Therapy
- 6.2.1 Market Overview
- 6.2.2 Standard Gene
- 6.2.3 Express Gene
- 6.2.4 Complex Gene
- 6.2.5 Others
- 6.3 Global Gene Synthesis Market by Application
- 6.3.1 Market Overview
- 6.3.2 Synthetic Biology
- 6.3.3 Genetic Engineering
- 6.3.4 Vaccine Design
- 6.3.5 Therapeutics Antibodies
- 6.3.6 Others
- 6.4 Global Gene Synthesis Market by Gene Synthesis Type
- 6.4.1 Market Overview
- 6.4.2 Gene Library Synthesis
- 6.4.3 Solid Phase Synthesis
- 6.4.4 Chip-Based DNA Synthesis
- 6.4.5 PCR-Based Enzyme Synthesis
- 6.5 Global Gene Synthesis Market by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Gene Synthesis Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Gene Synthesis Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Gene Synthesis Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Gene Synthesis Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Gene Synthesis Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Clinical Trials Analysis
- 15.1 Analysis by Trial Registration Year
- 15.2 Analysis by Trial Status
- 15.3 Analysis by Trial Phase
- 15.4 Analysis by Therapeutic Area
- 15.5 Analysis by Geography
- 16 Funding and Investment Analysis
- 16.1 Analysis by Funding Instances
- 16.2 Analysis by Type of Funding
- 16.3 Analysis by Funding Amount
- 16.4 Analysis by Leading Players
- 16.5 Analysis by Leading Investors
- 16.6 Analysis by Geography
- 17 Partnership and Collaborations Analysis
- 17.1 Analysis by Partnership Instances
- 17.2 Analysis by Type of Partnership
- 17.3 Analysis by Leading Players
- 17.4 Analysis by Geography
- 18 Supplier Landscape
- 18.1 ATDBio Ltd
- 18.1.1 Financial Analysis
- 18.1.2 Product Portfolio
- 18.1.3 Demographic Reach and Achievements
- 18.1.4 Mergers and Acquisitions
- 18.1.5 Certifications
- 18.2 General Biosystems
- 18.2.1 Financial Analysis
- 18.2.2 Product Portfolio
- 18.2.3 Demographic Reach and Achievements
- 18.2.4 Mergers and Acquisitions
- 18.2.5 Certifications
- 18.3 Macrogen CO.
- 18.3.1 Financial Analysis
- 18.3.2 Product Portfolio
- 18.3.3 Demographic Reach and Achievements
- 18.3.4 Mergers and Acquisitions
- 18.3.5 Certifications
- 18.4 Boster Biological Technology
- 18.4.1 Financial Analysis
- 18.4.2 Product Portfolio
- 18.4.3 Demographic Reach and Achievements
- 18.4.4 Mergers and Acquisitions
- 18.4.5 Certifications
- 18.5 Creative Biogene
- 18.5.1 Financial Analysis
- 18.5.2 Product Portfolio
- 18.5.3 Demographic Reach and Achievements
- 18.5.4 Mergers and Acquisitions
- 18.5.5 Certifications
- 18.6 Bioneer Pacific,
- 18.6.1 Financial Analysis
- 18.6.2 Product Portfolio
- 18.6.3 Demographic Reach and Achievements
- 18.6.4 Mergers and Acquisitions
- 18.6.5 Certifications
- 18.7 Exonbio
- 18.7.1 Financial Analysis
- 18.7.2 Product Portfolio
- 18.7.3 Demographic Reach and Achievements
- 18.7.4 Mergers and Acquisitions
- 18.7.5 Certifications
- 18.8 trenzyme GmbH
- 18.8.1 Financial Analysis
- 18.8.2 Product Portfolio
- 18.8.3 Demographic Reach and Achievements
- 18.8.4 Mergers and Acquisitions
- 18.8.5 Certifications
- 18.9 Twist Bioscience
- 18.9.1 Financial Analysis
- 18.9.2 Product Portfolio
- 18.9.3 Demographic Reach and Achievements
- 18.9.4 Mergers and Acquisitions
- 18.9.5 Certifications
- 18.10 BioCat GmbH
- 18.10.1 Financial Analysis
- 18.10.2 Product Portfolio
- 18.10.3 Demographic Reach and Achievements
- 18.10.4 Mergers and Acquisitions
- 18.10.5 Certifications
- 18.11 OriGene Technologies, Inc.
- 18.11.1 Financial Analysis
- 18.11.2 Product Portfolio
- 18.11.3 Demographic Reach and Achievements
- 18.11.4 Mergers and Acquisitions
- 18.11.5 Certifications
- 18.12 Integrated DNA Technologies
- 18.12.1 Financial Analysis
- 18.12.2 Product Portfolio
- 18.12.3 Demographic Reach and Achievements
- 18.12.4 Mergers and Acquisitions
- 18.12.5 Certifications
- 18.13 Eurofins Scientific
- 18.13.1 Financial Analysis
- 18.13.2 Product Portfolio
- 18.13.3 Demographic Reach and Achievements
- 18.13.4 Mergers and Acquisitions
- 18.13.5 Certifications
- 18.14 NZYTech
- 18.14.1 Financial Analysis
- 18.14.2 Product Portfolio
- 18.14.3 Demographic Reach and Achievements
- 18.14.4 Mergers and Acquisitions
- 18.14.5 Certifications
- 18.15 Genes and Enzymes
- 18.15.1 Financial Analysis
- 18.15.2 Product Portfolio
- 18.15.3 Demographic Reach and Achievements
- 18.15.4 Mergers and Acquisitions
- 18.15.5 Certifications
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.